Compound Detail
CHEMBL1096927
LEVOMENOL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL1096927 |
| Name | LEVOMENOL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | RGZSQWQPBWRIAQ-CABCVRRESA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
20
Publications
19
Known Names
2
Indications
Molecular Properties
222.4
MW (Da)
4.23
ALogP
1
HBA
1
HBD
20.2
PSA (Ų)
0.71
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Onychomycosis Wounds and Injuries
Activity Summary
IC50 3 meas. best 5.51
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL2492 | IC50 | 5.51 | 5.51 | 3100.0 | 1 |
| Leukemia cell CHEMBL614844 | IC50 | 4.85 | 4.85 | 14000.0 | 1 |
| Signal transducer and activator of transcription 3 CHEMBL4026 | IC50 | 4.14 | 4.14 | 73000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Neuronal acetylcholine receptor subunit alpha-7 | IC50 | = | 3100.0 | nM | 5.51 | Antagonist activity at human alpha7 nACHR expressed in Xenopus laevis oocytes as... | 30096653 |
| Leukemia cell | IC50 | = | 14000.0 | nM | 4.85 | Cytotoxicity against ALL/AML patient derived primary leukemia cells after 24 hrs... | 30096653 |
| Signal transducer and activator of transcription 3 | IC50 | = | 73000.0 | nM | 4.14 | Inhibition of IFNgamma-induced STAT3 activation in human HeLa cells expressing p... | 22309250 |
Literature References
Data from ChEMBL 36 via Core Engine